Bolden Therapeutics Email Formats

Biotechnology Research • Providence, Rhode Island, United States • 1-10 Employees

Bolden Therapeutics Email Formats

Bolden Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@boldentherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@boldentherapeutics.com	100%

Key Contact at Bolden Therapeutics

Anne Valat

Director of Research

Company overview

Headquarters	225 Dyer St, Providence, Rhode Island 02903, US
Website	boldentherapeutics.com
NAICS	541714
Founded	2019
Employees	1-10
Socials

About Bolden Therapeutics

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Bolden Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-10-16	9	$406,500
2024-02-09	1	N/A

Funding Insights

$406,500

Total funding amount

Number of funding rounds

Bolden Therapeutics Tech Stack

Discover the technologies and tools that power Bolden Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery

JavaScript libraries

GoDaddy

Hosting

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

core-js

JavaScript libraries

Frequently asked questions

Bolden Therapeutics is located in Providence, Rhode Island, US.

Bolden Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Bolden Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Bolden Therapeutics has raised a total of $406,500 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Bolden Therapeutics

Anne Valat

Director of Research

4.8

40,000 users